FFCP PHASE1:Mm9::chr10:127286973..127286982,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=216453|HGNC=|MCL_coexpression_id=252|UniProt=G5E8H9,E9QA87|association_with_transcript=-1bp_to_ENSMUST00000077530,ENSMUST00000165171,NM_147222,uc007hkt.1_5end|description=CAGE_peak_2_at_Rdh19_5end|id=chr10:127286973..127286982,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!1.87e-20!14;UBERON:0003918!1.87e-20!14;UBERON:0005095!1.87e-20!14;UBERON:0007687!1.87e-20!14;UBERON:0006554!9.04e-18!16;UBERON:0001008!1.15e-16!17;UBERON:0000489!2.72e-13!21|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.38e-43,14;UBERON:0003918,1.38e-43,14;UBERON:0011143,1.38e-43,14;UBERON:0005095,1.38e-43,14;UBERON:0007687,1.38e-43,14;UBERON:0006554,5.27e-34,18;UBERON:0001008,3.08e-32,19;UBERON:0000489,3.30e-29,21;UBERON:0003103,2.01e-14,43;UBERON:0005172,1.11e-12,49;UBERON:0005173,1.11e-12,49;UBERON:0002417,1.11e-12,49;UBERON:0000916,1.11e-12,49;UBERON:0003104,3.20e-10,61;UBERON:0009142,3.20e-10,61;UBERON:0009569,1.86e-09,66;UBERON:0005177,6.48e-08,79;UBERON:0002100,5.94e-07,90|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,3.05476991767971,5.81857461502877,6.45249542990931,15.9988438924371,10.1851002105925,8.79192875911699,3.45512058981041,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0640251524048693,0.114870937911227,0,0.115884325944855,0,0,0,0,0.177475806159338,0,0.145346416632329,0,0,0,0,0,0,0.118635018124174,0,0,0.154936841185966,0,0,0.467863216890817,0.429742108096597,0,0,0|short_description=p2@Rdh19}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:216453 | |||
|HGNC= | |||
|MCL_coexpression_id=252 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:G5E8H9,uniprot:E9QA87 | |||
|association_with_transcript=-1bp_to_ENSMUST00000077530,ENSMUST00000165171,NM_147222,uc007hkt.1_5end | |||
|cluster_id=chr10:127286973..127286982,+ | |||
|description=CAGE_peak_2_at_Rdh19_5end | |||
|id=chr10:127286973..127286982,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!1.87e-20!14;UBERON:0003918!1.87e-20!14;UBERON:0005095!1.87e-20!14;UBERON:0007687!1.87e-20!14;UBERON:0006554!9.04e-18!16;UBERON:0001008!1.15e-16!17;UBERON:0000489!2.72e-13!21 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.38e-43,14;UBERON:0003918,1.38e-43,14;UBERON:0011143,1.38e-43,14;UBERON:0005095,1.38e-43,14;UBERON:0007687,1.38e-43,14;UBERON:0006554,5.27e-34,18;UBERON:0001008,3.08e-32,19;UBERON:0000489,3.30e-29,21;UBERON:0003103,2.01e-14,43;UBERON:0005172,1.11e-12,49;UBERON:0005173,1.11e-12,49;UBERON:0002417,1.11e-12,49;UBERON:0000916,1.11e-12,49;UBERON:0003104,3.20e-10,61;UBERON:0009142,3.20e-10,61;UBERON:0009569,1.86e-09,66;UBERON:0005177,6.48e-08,79;UBERON:0002100,5.94e-07,90 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,3.05476991767971,5.81857461502877,6.45249542990931,15.9988438924371,10.1851002105925,8.79192875911699,3.45512058981041,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0640251524048693,0.114870937911227,0,0.115884325944855,0,0,0,0,0.177475806159338,0,0.145346416632329,0,0,0,0,0,0,0.118635018124174,0,0,0.154936841185966,0,0,0.467863216890817,0.429742108096597,0,0,0 | |||
|short_description=p2@Rdh19 | |||
}} |
Revision as of 01:56, 4 August 2015
Short description: | p2@Rdh19 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_2_at_Rdh19_5end |
Coexpression cluster: | MCL_coexpression_mm9:252 |
Association with transcript: | -1bp_to_ENSMUST00000077530, ENSMUST00000165171, NM_147222, uc007hkt.1_5end |
EntrezGene: | 216453 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.38e-43 | 14 |
kidney mesenchyme | 1.38e-43 | 14 |
upper urinary tract | 1.38e-43 | 14 |
kidney rudiment | 1.38e-43 | 14 |
kidney field | 1.38e-43 | 14 |
urinary system structure | 5.27e-34 | 18 |
renal system | 3.08e-32 | 19 |
cavitated compound organ | 3.30e-29 | 21 |
compound organ | 2.01e-14 | 43 |
abdomen element | 1.11e-12 | 49 |
abdominal segment element | 1.11e-12 | 49 |
abdominal segment of trunk | 1.11e-12 | 49 |
abdomen | 1.11e-12 | 49 |
mesenchyme | 3.20e-10 | 61 |
entire embryonic mesenchyme | 3.20e-10 | 61 |
subdivision of trunk | 1.86e-09 | 66 |
trunk region element | 6.48e-08 | 79 |
trunk | 5.94e-07 | 90 |